Cargando…
Two-Year Outcomes of Vagal Nerve Blocking (vBloc) for the Treatment of Obesity in the ReCharge Trial
BACKGROUND: The ReCharge Trial demonstrated that a vagal blocking device (vBloc) is a safe and effective treatment for moderate to severe obesity. This report summarizes 24-month outcomes. METHODS: Participants with body mass index (BMI) 40 to 45 kg/m(2), or 35 to 40 kg/m(2) with at least one comorb...
Autores principales: | Apovian, Caroline M., Shah, Sajani N., Wolfe, Bruce M., Ikramuddin, Sayeed, Miller, Christopher J., Tweden, Katherine S., Billington, Charles J., Shikora, Scott A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187356/ https://www.ncbi.nlm.nih.gov/pubmed/27506803 http://dx.doi.org/10.1007/s11695-016-2325-7 |
Ejemplares similares
-
Effect of Vagal Nerve Blockade on Moderate Obesity with an Obesity-Related Comorbid Condition: the ReCharge Study
por: Morton, John M., et al.
Publicado: (2016) -
Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge Trial
por: Shikora, Scott A., et al.
Publicado: (2015) -
Vagal Blocking Improves Glycemic Control and Elevated Blood Pressure in Obese Subjects with Type 2 Diabetes Mellitus
por: Shikora, S., et al.
Publicado: (2013) -
The effect of vagal nerve blockade using electrical impulses on glucose metabolism in nondiabetic subjects
por: Sathananthan, Matheni, et al.
Publicado: (2014) -
Vagal nerve stimulation started just prior to reperfusion limits infarct size and no-reflow
por: Uitterdijk, André, et al.
Publicado: (2015)